Biotech · Public company · Waltham, MA, US
Akebia Therapeutics, Inc.
Ticker AKBA · SEC CIK 0001517022
Track this companyFree. Adds Akebia Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials253 recruiting or active
Pipeline programs21From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline21
- Darbepoetin alfaPhase 3 · AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- Erythropoiesis-Stimulating Agent (ESA)Phase 3 · Anemia of Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Mircera®Phase 3 · Anemia Associated With Chronic Kidney Disease (CKD)ClinicalTrials.gov · fetched Nov 12, 2026
- VadadustatPhase 3 · AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- VadadustatPhase 3 · Anemia of Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- VadadustatPhase 3 · Anemia Associated With Chronic Kidney Disease (CKD)ClinicalTrials.gov · fetched Nov 12, 2026
- ADX-097Phase 2 · IgA NephropathyClinicalTrials.gov · fetched Nov 12, 2026
- AKB-6548Phase 2 · AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- Epoetin AlfaPhase 2 · AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- IW-1973Phase 2 · Heart Failure With Preserved Ejection FractionClinicalTrials.gov · fetched Nov 12, 2026
- IW-1973Phase 2 · Type 2 Diabetes Mellitus With Diabetic NephropathyClinicalTrials.gov · fetched Nov 12, 2026
- Praliciguat (Part A)Phase 2 · Focal Segmental GlomerulosclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Praliciguat (Part B)Phase 2 · Focal Segmental GlomerulosclerosisClinicalTrials.gov · fetched Nov 12, 2026
- VadadustatPhase 2 · Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Vadadustat TIWPhase 2 · AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- Darbepoetin alfaPhase 1 · Anemia Associated With Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Epoetin alfaPhase 1 · Anemia Associated With Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- vadadustatPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- VadadustatPhase 1 · Anemia Associated With Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- vadadustat reference tabletsPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- vadadustat test tabletsPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3GPHASE2 · RECRUITING · started Jul 30, 2026ClinicalTrials.gov NCT06419205 · fetched Nov 12, 2026
- A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)PHASE2 · RECRUITING · started Dec 3, 2025ClinicalTrials.gov NCT07268638 · fetched Nov 12, 2026
- Vadadustat for the Treatment of Nonintubated Acute Respiratory Distress Syndrome Due to Pathogen-Associated Lung InjuryPHASE2_PHASE3 · RECRUITING · started Oct 23, 2025ClinicalTrials.gov NCT07086755 · fetched Nov 12, 2026
- To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center HemodialysisPHASE3 · COMPLETED · started Jul 24, 2025ClinicalTrials.gov NCT06901505 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating AgentsPHASE3 · WITHDRAWN · started Jan 1, 2025ClinicalTrials.gov NCT05082584 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney DiseasePHASE3 · WITHDRAWN · started Jan 1, 2025ClinicalTrials.gov NCT05082571 · fetched Nov 12, 2026
- Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis SubjectsPHASE3 · COMPLETED · started Jun 18, 2021ClinicalTrials.gov NCT04707768 · fetched Nov 12, 2026
- Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)PHASE2 · COMPLETED · started Aug 22, 2020ClinicalTrials.gov NCT04478071 · fetched Nov 12, 2026
- Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs)PHASE3 · COMPLETED · started May 27, 2020ClinicalTrials.gov NCT04313153 · fetched Nov 12, 2026
- Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Hemodialysis Subjects With Anemia Associated With Chronic Kidney DiseasePHASE1 · COMPLETED · started May 28, 2019ClinicalTrials.gov NCT03992066 · fetched Nov 12, 2026
- Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin AlfaPHASE2 · COMPLETED · started Jan 31, 2019ClinicalTrials.gov NCT03799627 · fetched Nov 12, 2026
- A Study in Evaluating Bioequivalence of Test and Reference Vadadustat 450 MG and 150 MG Tablets and to Determine Food Effect on the 450 MG TabletPHASE1 · COMPLETED · started Aug 3, 2018ClinicalTrials.gov NCT03657290 · fetched Nov 12, 2026
- A Study in Evaluating Bioequivalence Between Test and Reference Formulations of Vadadustat Tablets in Healthy AdultsPHASE1 · COMPLETED · started Apr 12, 2018ClinicalTrials.gov NCT03639155 · fetched Nov 12, 2026
- A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)PHASE2 · COMPLETED · started Nov 7, 2017ClinicalTrials.gov NCT03254485 · fetched Nov 12, 2026
- A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by AlbuminuriaPHASE2 · COMPLETED · started Aug 1, 2017ClinicalTrials.gov NCT03217591 · fetched Nov 12, 2026
- Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating AgentsPHASE2 · TERMINATED · started May 2, 2017ClinicalTrials.gov NCT03140722 · fetched Nov 12, 2026
- Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD)PHASE3 · COMPLETED · started Aug 1, 2016ClinicalTrials.gov NCT02892149 · fetched Nov 12, 2026
- Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Participants With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)PHASE3 · COMPLETED · started Jul 1, 2016ClinicalTrials.gov NCT02865850 · fetched Nov 12, 2026
- Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)PHASE3 · COMPLETED · started Feb 1, 2016ClinicalTrials.gov NCT02680574 · fetched Nov 12, 2026
- Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney DiseasePHASE3 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02648347 · fetched Nov 12, 2026
- 16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic HemodialysisPHASE2 · COMPLETED · started Sep 10, 2014ClinicalTrials.gov NCT02260193 · fetched Nov 12, 2026
- 20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and AnemiaPHASE2 · COMPLETED · started Jul 23, 2013ClinicalTrials.gov NCT01906489 · fetched Nov 12, 2026
- 42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and AnemiaPHASE2 · COMPLETED · started Jun 15, 2011ClinicalTrials.gov NCT01381094 · fetched Nov 12, 2026
- Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and AnemiaPHASE2 · COMPLETED · started Oct 21, 2010ClinicalTrials.gov NCT01235936 · fetched Nov 12, 2026
- Study to Assess the Safety and Pharmacokinetics of AKB-6548 in Participants With Chronic Kidney Disease (CKD), Stages 3 and 4PHASE2 · COMPLETED · started Jul 8, 2010ClinicalTrials.gov NCT04707573 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 23, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 14, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 22, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 1, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Feb 26, 2026 · fetched Nov 12, 2026